ERBB2 blocks anoikis in breast cancer cells by downregulating the pro-apoptotic proteins Perp and Bim in a Mek-dependent manner (Reginato et al., 2003; Khan et al., 2016). The gene discussed is BCL2L11; the disease is breast cancer.